[1]程贵胜.急诊介入联合抽吸导管对急性ST段抬高型心肌梗死伴心力衰竭患者预后及心室重构的影响[J].医学信息,2024,37(02):128-131.[doi:10.3969/j.issn.1006-1959.2024.02.025]
　CHENG Gui-sheng.Effect of Emergency Intervention Combined with Aspiration Catheter on Prognosis and Ventricular Remodeling in Patients with Acute ST-segment Elevation Myocardial Infarction Complicated with Heart Failure[J].Journal of Medical Information,2024,37(02):128-131.[doi:10.3969/j.issn.1006-1959.2024.02.025]
点击复制

急诊介入联合抽吸导管对急性ST段抬高型心肌梗死伴心力衰竭患者预后及心室重构的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年02期
页码:
128-131
栏目:
论著
出版日期:
2024-01-15

文章信息/Info

Title:
Effect of Emergency Intervention Combined with Aspiration Catheter on Prognosis and Ventricular Remodeling in Patients with Acute ST-segment Elevation Myocardial Infarction Complicated with Heart Failure
文章编号:
1006-1959（2024）02-0128-04
作者:
程贵胜
（修水县第一人民医院南院心血管内科，江西 修水 332400）
Author(s):
CHENG Gui-sheng
(Cardiovascular Department of Internal Medicine,South Branch,Xiushui County First People’s Hospital,Xiushui 332400,Jiangxi,China)
关键词:
急性ST段抬高型心肌梗死; 心力衰竭; 经皮冠状动脉介入; 抽吸导管; 心室重构
Keywords:
Acute ST-segment elevation myocardial infarction; Heart failure; Percutaneous coronary intervention; Aspiration catheter; Ventricular remodeling
分类号:
R542.2+2
DOI:
10.3969/j.issn.1006-1959.2024.02.025
文献标志码:
A
摘要:
目的 探究急诊经皮冠状动脉介入（PCI）联合抽吸导管对急性ST段抬高型心肌梗死（STEMI）伴心力衰竭（HF）患者预后及心室重构的影响。方法 以2019年10月-2022年10月修水县第一人民医院收治的100例STEMI伴HF患者为研究对象，经随机数字表法分为对照组与观察组，各50例。对照组直接行急诊PCI治疗，观察组则采用PCI联合抽吸导管治疗，比较两组术后疗效（TIMI血流分级、术后2 h ST段回落率）、心肌损伤指标[肌酸激酶同工酶（CK-MB）、肌钙蛋白Ⅰ（cTnⅠ）]、心室重构指标[左室后壁厚度（LVPWT）、室间隔厚度（IVST）、左心室质量（LVM）]、术后3个月主要心血管事件（MACE）。结果 观察组术后TIMI血流分级、术后2 h ST段回落率均高于对照组（P＜0.05）；两组术后CK-MB、cTnⅠ低于术前，且观察组低于对照组（P＜0.05）；两组术后LVPWT、IVST小于术前，LVMI大于术前，且观察组LVPWT、IVST小于对照组，LVMI大于对照组（P＜0.05）；两组术后3个月MACE发生率比较，差异无统计学意义（P＞0.05）。结论 急诊PCI联合血栓抽吸导管在STEMI伴HF治疗中具有确切疗效，可进一步改善心肌血流灌注与ST段回落幅度，减轻患者心肌损伤，抑制心室重构，且不增加术后MACE风险。
Abstract:
bjective To investigate the effect of emergency percutaneous coronary intervention (PCI) combined with aspiration catheter on prognosis and ventricular remodeling in patients with acute ST-segment elevation myocardial infarction (STEMI) complicated with heart failure (HF).Methods A total of 100 STEMI patients with HF admitted to Xiushui County First People’s Hospital from October 2019 to October 2022 were divided into control group and observation group by random number table method, with 50 patients in each group. The control group was treated with emergency PCI directly, while the observation group was treated with PCI combined with aspiration catheter. The postoperative efficacy (TIMI blood flow grade, ST segment fall rate at 2 h after operation), myocardial injury indexes [creatine kinase isoenzyme (CK-MB), troponin Ⅰ ( cTnⅠ)], ventricular remodeling indexes [left ventricular posterior wall thickness (LVPWT), interventricular septum thickness (IVST), left ventricular mass (LVM)] and major cardiovascular events (MACE) at 3 months after operation were compared between the two groups.Results The TIMI blood flow grade and ST segment resolution rate at 2 h after operation in the observation group were higher than those in the control group (P<0.05). The levels of CK-MB and cTnⅠ in the two groups after operation were lower than those before operation, and those in the observation group were lower than those in the control group (P<0.05). The LVPWT and IVST of the two groups after operation were lower than those before operation, and the LVMI was higher than that before operation, while the LVPWT and IVST of the observation group were lower than those of the control group, and the LVMI was higher than that of the control group (P<0.05). There was no significant difference in the incidence of MACE between the two groups at 3 months after operation (P>0.05).Conclusion Emergency PCI combined with aspiration catheter has a definite effect in the treatment of STEMI with HF, which can further improve myocardial perfusion and ST segment resolution, reduce myocardial injury, inhibit ventricular remodeling, and do not increase the risk of postoperative MACE.

参考文献/References:

[1]龚杨,徐敏,黄鹤.ST段抬高型心肌梗死伴射血分数中间值心力衰竭的临床特征分析[J].中国循证心血管医学杂志,2019,11(8):924-927,941.[2]张家瑞,白文伟,李颖,等.直接经皮冠状动脉介入治疗联合冠脉内溶栓对急性ST段抬高型心肌梗死患者CTFC的影响[J].四川医学,2022,43(7):671-676.[3]武艳强,侯爱军,傅向华,等.经导管靶向溶栓对ST段抬高型心肌梗死患者微循环的保护价值[J].国际老年医学杂志,2022,43(3):321-326.[4]杨培根,程爱娟,李鹏,等.急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗术后1年内非计划再入院的危险因素[J].中华高血压杂志,2022,30(5):474-478.[5]冯英.溶栓后转运PCI与直接PCI治疗急性ST段抬高型心肌梗死的临床效果[J].中西医结合心脑血管病杂志,2021,19(10):1709-1711.[6]马飞虹,乔增勇.血栓抽吸联合微导管靶向应用重组人尿激酶原对ST抬高型急性心肌梗死患者心肌血流灌注的影响[J].临床心血管病杂志,2020,36(12):1088-1092.[7]陈波,王国宏,陈喆,等.经血栓抽吸导管应用替罗非班及硝普钠对急性前壁ST段抬高型心肌梗死患者急诊PCI治疗效果的影响[J].现代生物医学进展,2020,20(11):2064-2067.[8]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志,2019,47(10):766-783.[9]路翔宇,滕天琦,夏勇.行急诊经皮冠状动脉介入治疗的青年急性ST段抬高型心肌梗死患者的临床特点及住院期间预后分析[J].实用心脑肺血管病杂志,2020,28(5):96-102.[10]熊永红,王静,李雪玲,等.急性ST段抬高型心肌梗死合并射血分数保留的心力衰竭患者急诊经皮冠状动脉介入治疗术中无复流的影响因素分析[J].中国心血管病研究,2020,18(3):227-231.[11]卢鹏飞,张波,李永旺,等.急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗术后不同左心室射血分数患者的临床特征及预后多中心比较研究[J].中国循环杂志,2019,34(11):1068-1073.[12]刘美丽,黄光华,李娜,等.合并心力衰竭ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗临床疗效分析[J].临床军医杂志,2019,47(11):1174-1177.[13]刘金武,荣晶晶,刘征宇,等.血栓抽吸联合冠状动脉内溶栓对急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗术后冠状动脉微循环的影响[J].中国循环杂志,2022,37(11):1097-1104.[14]毛幼林,袁义强,王瑞敏,等.不同给药途径预防急性心肌梗死病人血栓抽吸后慢血流的临床疗效[J].中西医结合心脑血管病杂志,2019,17(8):1206-1209.[15]陈伟,伍于斌.血栓抽吸术联合PCI对急性ST段抬高型心肌梗死患者血清ITLN-1水平的影响[J].海南医学,2019,30(2):175-179.[16]白文楼,孟存良,陈学锋,等.血栓抽吸联合重组人尿激酶原对急性心肌梗死急诊PCI术后慢血流或无复流的影响[J].临床心血管病杂志,2019,35(1):70-74.[17]曹兴阳,朱亚男,张波.高龄急性ST段抬高型心肌梗死行直接经皮冠状动脉介入治疗患者的预后分析[J].中国介入心脏病学杂志,2019,27(12):693-699.[18]滕继伟,张辉,冯达云,等.经血栓抽吸导管注射替罗非班治疗急性ST段抬高型心肌梗死的效果[J].中华实用诊断与治疗杂志,2019,33(1):75-77.[19]李学香.经导管预处理血栓对ST段抬高型心肌梗死直接冠状动脉介入术的影响和临床意义[J].新医学,2018,49(8):590-595.[20]张强,陈会校,刘珂,等.血栓抽吸并经血栓抽吸导管注射尿激酶原对ST段抬高型心肌梗死患者经皮冠状动脉介入治疗效果的影响[J].实用心脑肺血管病杂志,2018,26(7):110-112,116.[21]李文强,马震.替罗非班联合血栓抽吸在急诊PCI治疗STIMI中的效果及预后分析[J].国际医药卫生导报,2022,28(23):3380-3384.

相似文献/References:

[1]郭俊林,张立.BNP对CRT后期疗效的临床评价[J].医学信息,2018,31(01):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
　GUO Jun-lin,ZHANG li.Clinical Evaluation of BNP in Treatment of Late CRT[J].Journal of Medical Information,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
[2]程 林.重组人脑利钠肽用于重症急性心肌炎伴 心力衰竭患者治疗的临床研究[J].医学信息,2018,31(08):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
　CHENG Lin.Clinical Study of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Severe Acute Myocarditis and Heart Failure[J].Journal of Medical Information,2018,31(02):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
[3]胡丽君.螺内酯联合曲美他嗪治疗慢性心力衰竭的疗效分析[J].医学信息,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
　HU Li-jun.Efficacy of Spironolactone Combined with Trimetazidine in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2018,31(02):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
[4]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(02):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[5]何玲玲,程淑芬.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭疗效观察[J].医学信息,2018,31(13):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
　HE Ling-ling,CHENG Shu-fen.Therapeutic Effect of Trimetazidine Combined with Metoprolol Succinate in the Treatment of Coronary Heart Disease with Heart Failure[J].Journal of Medical Information,2018,31(02):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
[6]赵 维,廖荣宏,王爱华.糖皮质激素治疗心力衰竭疗效与安全性的Meta分析[J].医学信息,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
　ZHAO Wei,LIAO Rong-hong,WANG Ai-hua.Meta-analysis of the Efficacy and Safety of Glucocorticoids in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(02):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
[7]施国富,吴春阳,施亚明,等.血浆脑钠肽对射血分数保留心力衰竭患者的诊断价值研究[J].医学信息,2018,31(16):47.[doi:10.3969/j.issn.1006-1959.2018.16.013]
　SHI Guo-fu,WU Chun-yang,SHI Ya-ming,et al.Diagnostic Value of Plasma Brain Natriuretic Peptide in Patients with Heart Failure Preserved by Ejection Fraction[J].Journal of Medical Information,2018,31(02):47.[doi:10.3969/j.issn.1006-1959.2018.16.013]
[8]李 宁,胡硕强.心脏再同步治疗心力衰竭的文献计量分析[J].医学信息,2018,31(19):79.[doi:10.3969/j.issn.1006-1959.2018.19.024]
　LI Ning,HU Shou-qiang.Bibliometric Analysis of Cardiac Resynchronization in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(02):79.[doi:10.3969/j.issn.1006-1959.2018.19.024]
[9]颜 琼,王 静,胡 聪.慢性心力衰竭患者半年内重返住院的调查分析与对策[J].医学信息,2018,31(20):173.[doi:10.3969/j.issn.1006-1959.2018.20.055]
　YAN Qiong,WANG Jing,HU Cong.Investigation and Countermeasures of Patients with Chronic Heart Failure Returning to Hospital within Half a Year[J].Journal of Medical Information,2018,31(02):173.[doi:10.3969/j.issn.1006-1959.2018.20.055]
[10]杨锦龙,刘 欢.甲状腺激素测定在高血压心力衰竭患者中的临床意义[J].医学信息,2018,31(22):96.[doi:10.3969/j.issn.1006-1959.2018.22.026]
　YANG Jin-long,LIU Huanc.Clinical Signifcance of Changes of Serum Thyroid Hormone Levels in Hypertensive Patients with Chronic Heart Failure[J].Journal of Medical Information,2018,31(02):96.[doi:10.3969/j.issn.1006-1959.2018.22.026]

更新日期/Last Update: 1900-01-01